UNSPSC 51381602: Parcetasal

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H15NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3LSZ7869T2, chemically known as acetamide, n-(4-((2-methyl-4-oxo-4h-1,3-benzadioxin-2-yl)oxy)-phenyl)- but generally known as parcetasal, which bears US NIH Compound Identifier 65656. European Medicines Agency schedules Parcetasal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09621MIG.

UNSPSC 51381602 Parcetasal is a Commodity code under which state and local governments procure pharmaceutical and chemical products, though recent solicitation activity shows a marked divergence: the code designation references parcetamol (acetaminophen), but the two identifiable opportunities—one for sodium bisulfite water-treatment chemical and one for generic multi-source pharmaceuticals and OTC products—reflect broader chemical supply and pharmaceutical distribution rather than a single active pharmaceutical ingredient. The actual buying pattern under this code encompasses both specialty chemicals for municipal water-treatment operations and generic pharmaceutical commodities distributed through established wholesale channels to government facilities. Issuing bodies include municipal utility departments (water pollution control facilities) and state-level cooperative purchasing alliances coordinating multi-state procurement on behalf of participating state and local government members.

The most recent activity spans Connecticut and Minnesota. The City of Meriden posted an IFB (solicitation B02715) on July 8, 2026, due July 29, 2026, for sodium bisulfite chemical supply to its Water Pollution Control Facility, requiring $1,000,000 to $2,000,000 in General Liability coverage and a performance bond. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) posted January 20, 2026, due March 26, 2026, for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities including Oregon; awards were to be provided to authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) by May 15, 2026, with contracts effective July 1, 2026. The code shows limited recent posting volume and a scattershot relationship to its nominal pharmaceutical classification, suggesting either low current demand or persistent tagging misalignment between state and local procurement systems and actual commodity scope.